Once the specificity of c-Myc suppression in HCC cell lines was established, we aimed to increase the level of specificity further by packaging the AFP promoter/enhancer shRNA constructs within the Sendai virosomes for liver specific delivery. This evidence concerns the gene MYC and hepatocellular carcinoma.